The ten-year contract, valued at up to $25.5 million, is designed to ensure that critical treatment resources are immediately available when large-scale burn incidents occur, a scenario where speed and scalability can determine survival outcomes.
A decade of readiness as AVITA medical expands burn response capability
April 9, 2026 Australian Biotech
Latest Video
New Stories
-
A decade of readiness as AVITA medical expands burn response capability
April 9, 2026 - - Australian Biotech -
Moderna names Carolyn Tucek-Szabo to lead Australia and New Zealand operations
April 9, 2026 - - Latest News -
New Zealand's Pharmac announces a shift in treatment for blood cancer
April 9, 2026 - - Latest News -
It is imperative to very carefully read what the minister said, and then read it again
April 9, 2026 - - Latest News -
Stuart Dignam joins MTPConnect board as it embarks on its second decade
April 8, 2026 - - Latest News -
A frontline of everyday healthcare and its critical role in addressing stigma
April 8, 2026 - - Latest News -
Orthocell minimises US tariff threat as Australian biotechs play down impact
April 8, 2026 - - Australian Biotech
